Jaka jest cena za QuantRx Biomedical Corporation (QTXB)

Cena za QuantRx Biomedical Corporation (QTXB) wynosi $0.0005

Jaka jest kapitalizacja rynkowa dla QuantRx Biomedical Corporation (QTXB)

Kapitalizacja rynkowa dla QuantRx Biomedical Corporation (QTXB) wynosi $118.05K

Przychody QuantRx Biomedical Corporation (QTXB)

QuantRx Biomedical Corporation is engaged in the creation and marketing of its patented miniature pads (PADs) and related over-the-counter (OTC) products within the United States. Additionally, the company is developing genomic diagnostic tools for the laboratory market, leveraging its proprietary lateral flow technologies, including the RapidSense single-step lateral flow test. The company's PAD products are designed to address a range of medical conditions such as hemorrhoids, mild vaginal infections, urinary incontinence, menstrual hygiene, and other general medical needs. Key offerings include InSync, an interlabial pad for feminine hygiene. Another significant product is the Unique miniform, which comes in two forms: a medicated pad providing temporary relief from the itching and discomfort associated with hemorrhoids and minor vaginal infections, and an unmedicated pad for daily management of light urinary, vaginal, or anal leakage. Other treated miniform products are also part of their portfolio. Established in 1986, QuantRx Biomedical Corporation is headquartered in Tualatin, Oregon.

Rok	Przychody	Zmień
Za mało danych dla podanych dat.

Rok

Przychody

Zmień

Za mało danych dla podanych dat.

Firma	Przychody	Różnica w przychodach	Kraj
Intuitive Surgical, Inc. ISRG.US	$11.03B	-	US
EssilorLuxottica S.A. EL.PA	$34.74B	-	FR
HOYA Corporation 7741.T	-	-	JP
Becton, Dickinson and Company BDX.US	$20.84B	-	US
Alcon Inc. ALC.SW	-	-	CH

Firma

Przychody

Różnica w przychodach

Kraj